46.46.Z - Wholesale of pharmaceutical goods
46.18.Z - Agents specialised in the sale of other particular products
46.76.Z - Wholesale of other intermediate products
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.78.Z - Other retail sale of new goods in specialised stores
63.99.Z - Other information service activities not elsewhere classified
72.19.Z - Other research and experimental development on natural sciences and engineering
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
82.99.Z - Other business support service activities not elsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Net sales | 1,6 | 1,7 | 1,7 | 1 |
Liabilities and provisions | 0,3 | 0,3 | 0,3 | -2,3 |
Equity | 0,9 | 0,9 | 1 | 6,8 |
Total assets | 1,1 | 1,3 | 1,3 | 4,4 |
Cash and cash equivalents | 0,7 | 0,6 | 0,6 | -0,5 |
Depreciation | 0 | 0 | 0 | 0 |
Gross profit / loss | -0 | 0,1 | 0,1 | -19,1 |
EBITDA | -0 | 0,1 | 0,1 | -17 |
Net profit / loss | -0 | 0,1 | 0,1 | -31,7 |
Operating profit (EBIT) | -0 | 0,1 | 0,1 | -17 |
Current assets | 1,1 | 1,3 | 1,3 | 4,4 |
% | % | % | p.p. | |
Return on equity (ROE) | -4,4 | 9,9 | 6,3 | -3,6 |
Return on sales (ROS) | -2,3 | 5,4 | 3,7 | -1,7 |
Equity ratio | 75,5 | 73,9 | 75,6 | 1,7 |
EBITDA margin | -1,1 | 7,5 | 6,1 | -1,4 |
Gross profit margin | -1,1 | 7,5 | 6 | -1,5 |
Days | Days | Days | Days | |
Current liabilities turnover ratio | 2 | 5 | 8 | 3 |
Current ratio | 23,3 | 33,3 | 21,8 | -11,5 |
Net debt to EBITDA | 39,8 | -4,9 | -5,9 | -1 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.